Dr. Kaplan comes to SHEPHERD from Genzyme, where she served as Vice President of Research. Over the course of her 24-year career in biotechnology, Johanne directed pioneering research and partnerships leading to the implementation of multiple clinical trials in the fields of gene therapy, autoimmunity, and oncology. She led the scientific research support of several approved drugs in the oncology space including alemtuzumab, clofarabine, and plerixafor. Prior to joining Genzyme, Johanne was an Associate Immunopathologist at SmithKline Beecham where she established an immunotoxicology program. Her work has resulted in over 60 scientific publications and multiple patents. Johanne holds a B.Sc. and a Ph.D. in Microbiology & Immunology from McGill University in Montreal, Canada and conducted post-doctoral studies at the Albert Einstein College of Medicine in New York.
Johanne is a life-long scientist, who values critical thinking and efficiency. Her most efficient day to date: she had a job interview in the morning and went into labor in the afternoon. A brand new baby boy and a new job the next day!